You just read:

Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP)

News provided by

Cempra Pharmaceuticals

Sep 15, 2011, 07:00 ET